Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates

Gut

Volumn 62, Issue 10, 2013, Pages 1497-1504

  Goldbecker, Annemarie ^a   Weissenborn, Karin ^a   Shahrezaei, Golschan Hamidi ^a   Afshar, Kambiz ^a   Rümke, Stefan ^a   Barg Hock, Hannelore ^a   Strassburg, Christian P ^a,b   Hecker, Hartmut ^a   Tryc, Anita Blanka ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; COMPARATIVE STUDY; CONSENSUS; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DIABETES MELLITUS; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HUMAN; INHIBITORY CONTROL TEST; KIDNEY FAILURE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PORTOSYSTEMIC ENCEPHALOPATHY SYNDROME TEST; PRIORITY JOURNAL; PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; SENSITIVITY AND SPECIFICITY;

BRAIN/GUT INTERACTION; HEPATIC ENCEPHALOPATHY; LIVER TRANSPLANTATION;

ADULT; AGED; CASE-CONTROL STUDIES; EDUCATIONAL STATUS; FEMALE; FLICKER FUSION; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; WAITING LISTS; YOUNG ADULT;

EID: 84884280726     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303262     Document Type: Article

References (31)

1. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001;16:37-41. (Pubitemid 33064035)
2. Schomerus H, Hamster W, Blunck H, et al. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981;26:622-30. (Pubitemid 11093388)
3. Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010;362:1071-81.
4. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70. (Pubitemid 32119037)
5. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903. (Pubitemid 38670122)
6. Stewart CA, Malinchoc M, Kim WR, et al. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007;13:1366-71. (Pubitemid 47629568)
7. Bajaj JS, Cordoba J, Mullen KD, et al. Review article: the design of clinical trials in hepatic encephalopathy-an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 2011;33:739-47.
8. Randolph C, Hilsabeck R, Kato A, et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009;29:629-35.
9. Schomerus H, Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998;13:361-77. (Pubitemid 29063735)
10. Romero-Gomez M, Cordoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45:879-85. (Pubitemid 46631556)
11. Weissenborn K, Ahl B, Fischer-Wasels D, et al. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 2007;56:1736-42. (Pubitemid 350206301)
12. Sharma P, Sharma BC, Sarin SK. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int 2009;29:1365-71.
13. Weissenborn K, Ennen JC, Schomerus H, et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001;34:768-73. (Pubitemid 32488796)
14. Dhiman RK, Kurmi R, Thumburu KK, et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 2010;55:2381-90.
15. Amodio P, Campagna F, Olianas S, et al. Detection of minimal hepatic encephalopathy: normalization and optimization of the psychometric hepatic encephalopathy score. A neuropsychological and quantified EEG study. J Hepatol 2008;49:346-53.
16. Mooney S, Hasssanein TI, Hilsabeck RC, et al. Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant. Arch Clin Neuropsychol 2007;22:175-86. (Pubitemid 46356880)
17. Kircheis G, Wettstein M, Timmermann L, et al. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002;35:357-66. (Pubitemid 34106375)
18. Sharma P, Sharma BC, Puri V, et al. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007;47:67-73. (Pubitemid 46830721)
19. Bajaj JS, Saeian K, Verber MD, et al. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 2007;102:754-60. (Pubitemid 46496606)
20. Amodio P, Ridola L, Schiff S, et al. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 2010;139:510-18, 518 e511-512.
21. Randolph C, Tierney MC, Mohr E, et al. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998;20:310-19. (Pubitemid 28539551)
22. Rose C, Jalan R. Is minimal hepatic encephalopathy completely reversible following liver transplantation? Liver Transpl 2004;10:84-7. (Pubitemid 38885898)
23. Bajaj JS, Hafeezullah M, Hoffmann RG, et al. Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008;47:596-604. (Pubitemid 351280728)
24. Bajaj JS, Hafeezullah M, Zadvornova Y, et al. The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am J Gastroenterol 2009;104:898-905.
25. Misiak H. The decrease of critical flicker frequency with age. Science 1951;113:551-2.
26. Eckstein AK, Reichenbach A, Jacobi P, et al. Hepatic retinopathia. Changes in retinal function. Vision Res 1997;37:1699-706. (Pubitemid 27277618)
27. Garner CD, Lee EW, Louis-Ferdinand RT. Muller cell involvement in methanol-induced retinal toxicity. Toxicol Appl Pharmacol 1995;130:101-7.
28. Pfefferbaum A, Sullivan EV, Rosenbloom MJ, et al. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry 1998;55:905-12. (Pubitemid 28465780)
29. Sotil EU, Gottstein J, Ayala E, et al. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl 2009;15:184-92.
30. Meyer T, Eshelman A, Abouljoud M. Neuropsychological changes in a large sample of liver transplant candidates. Transplant Proc 2006;38:3559-60. (Pubitemid 44908437)
31. Montagnese S, Biancardi A, Schiff S, et al. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology 2011;53:558-66.